Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of ensitrelvir granules in pediatric participants <6 years with SARS-CoV-2 infection
jRCT2031250501Phase 3Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ensitrelvir in coronavirus disease 2019 (COVID-19), sponsored by Shionogi & Co., Ltd. Started Nov 2025; status: recruiting.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031250501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250501.